Penn Medicine Provider
Medical Oncology
Nevena Damjanov, MD
4.9
(82)
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Penn Presbyterian
Make an appointmentCall 215-662-9801

About me

  • Section Chief Hematology/Oncology, VA Medical Center
  • Director of Gastrointestinal Oncology, Abramson Cancer Center, Penn Presbyterian Medical Center
  • Professor of Clinical Medicine (Hematology-Oncology)

Education and training

  • Medical School: Drexel University Center City Hahnemann Campus
  • Residency: Penn State Milton S. Hershey Medical Center
  • Fellowship: Hospital of the University of Pennsylvania
  • Fellowship: University Hospitals Case Medical Center

What my patients think about me

Average Rating
4.9

82 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
she is extremely professional. she shows compassion and kindness. her all around demeanor is above and beyond!
May 2025
5.0
5.0
good job
April 2025
5.0
5.0
good clinician
April 2025
5.0
5.0
i have the highest regard for dr. damjanov.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Damjanov is a Penn Medicine physician.

Qualifications and experience

My research

Mari Angelica Cayabyab1, Glenda Hoffecker, Lisa Varughese, Victoria Wittner, Jean De Dieu Ndayishimiye, Xingmei Wang, Joseph Bleznuck, Rachel Hatch1, Donna Capozzi, Avni Santani, Hakon Hakonarson, Ryan C. Massa, Nevena Damjanov, Nandi J. Reddy, Randall A. Oyer, Ursina R. Teitelbaum, Sony Tuteja From paper to practice: Implementing preemptive Dihydropyridine dehydrogenase (DPYD) testing & pharmacogenomic (PGx)-guided dosing to reduce serious treatment-related adverse events (TRAEs) in gastrointestinal malignancies , ACCP: 2024

Monica M. Matsumoto, MD, Enrique F. Schisterman, PhD, Michael C. Soulen, MD, Shilpa Reddy, MD, Mike Sheng, MD, Tamim Khaddash, MD, Nevena Damjanov, MD, Emma E. Furth, MD, Stephen J. Hunt, MD PhD, Gregory J. Nadolski, MD MTR, David E. Kaplan, MD MSc, Terence P.F. Gade, MD PhD Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma: The Phase I-II qTACE Trial , Journal of Vascular and Interventional Radiology: 2024

Sony Tuteja, Mari Cayabyab, Glenda Hoffecker, Lisa A. Varughese, Jean De Dieu. Ndayishimiye, Victoria Wittner, Xingmei Wang, Margaret Harr, Avni Santani, Hakon Hakonarson, Ryan Massa, Nevena Damjanov, Nandi Reddy, Randy Oyer, Ursina R. Teitelbaum Implementing DPYD/UGT1A1 testing to prevent treatment related adverse events (TRAE) in patients with gastrointestinal (GI) cancer: results of a pragmatic implementation trial , J Clin Oncol: 2024

Michael C Soulen, Ursina R Teitelbaum, Rosemarie Mick, Jennifer Eads, Jeffrey I Mondschein, Mandeep Dagli, Diana van Houten, Nevena Damjanov, Charles Schneider, Keith Cengel, David C Metz Integrated capecitabine-temozolomide with radioembolization for liver-dominant G2 NETs: long-term outcomes of a single-institution retrospective study , Cardiovasc Intervent Radiol : 2024

Sony Tuteja, Mari Cayabyab, Glenda Hoffecker, Lisa A. Varughese, Jean D. Ndayishimiye, Victoria Wittner, Xingmei Wang, Rachel Hatch, Donna Capozzi, Margaret Harr, Avni Santani, Hakon Hakonarson, Ryan Massa, Nevena Damjanov, Nandi Reddy, Randy Oyer, Ursina R. Teitelbaum Implementing DPYD/UGT1A1 testing to prevent treatment related adverse events (TRAEs) in patients with gastrointestinal (GI) cancer: results of a pragmatic implementation trial , ClinPGx 2024: Knowledge, Implementation & Education: 2024

Jeffrey W. Shevach, MD, Lisa B. Aiello, PhD, RN, AOCNS, Julie A. Lynch, PhD, RN, MBA, Jeffrey Petersen, MD, Lori Hoffman-Hogg, MS, RN, CNS, AOCN, Deborah Hartzfeld, MS, Margaret Lundquist, DNP, MPH, CRNP, Michael J. Kelley, MD, Maren T. Scheuner, MD, MPH, Robert Montgomery, MD Nevena Damjanov, MD Kyle Robinson, MD, Yu-Ning Wong, MD, Darshana Jhala, MD, Ravi B. Parikh, MD, MPH, and Kara N. Maxwell, MD, PhD On-Site Nurse-Led Cancer Genetics Program Increases Cancer Genetic Testing Completion in Black Veterans , JCO Oncology Practice, 19(8): 2023

Damjanov, N Clinical Edge Journal Scan Commentary: HCC , MDEdge: 2022

Damjanov, N Clinical Edge Journal Scan Commentary: HCC , MDEdge: 2022

Damjanov, N Clinical Edge Journal Scan Commentary: HCC , MDEdge: 2022

Damjanov, N Clinical Edge Journal Scan Commentary: HCC , MDEdge: 2022